BRAK (CXCL14) humain, ;, recombinant, exprimé en E. coli, > = 98 % (SDS - PAGE ), >= 98%( HPLC) , testé sur la culture CELLULAIRE

Code: srp3019-20ug D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently ex...


en savoir plus

Votre prix
$418.76 20UG

Non disponible en dehors du Royaume-Uni et de l'Irlande

Biochem/physiol Actions

Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues.

General description

Breast and Kidney-expressed chemokine (BRAK) is a CXC chemokine expressed in normal tissue in the absence of inflammatory stimuli, and infrequently expressed in cancer cell lines. BRAK is known to be a highly selective monocyte chemoattractant. However, main function and receptor selectivity is unknown at this time. BRAK contains the four highly conserved cysteine residues present in CXC chemokines. The sequence of the mature protein consists of 87 amino acid residues, and is approximately 30% homologous to the sequences of MIP-2 alpha and beta. Recombinant human BRAK is a 9.4 kDa protein containing 77 amino acid residues.

Physical form

Lyophilized with no additives.

Reconstitution

Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1-1.0 mg/ml. Do not vortex. This solution can be stored at 2-8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at -20°C to -80°C.

Sequence

SKCKCSRKGP KIRYSDVKKL EMKPKYPHCE EKMVIITTKS VSRYRGQEHC LHPKLQSTKR FIKWYNAWNE KRRVYEE

assay≥98% (SDS-PAGE), ≥98% (HPLC)
biological sourcehuman
colorwhite to off-white
formlyophilized
Gene Informationhuman ... CXCL14(9547)
impurities﹤0.1 EU/µg endotoxin, tested
mol wt9.4 kDa
packagingpkg of 20 µg
potency1.0-10.0 ng/mL
recombinantexpressed in E. coli
shipped inwet ice
storage temp.−20°C
technique(s)cell culture | mammalian: suitable
UniProt accession no.O95715
Ce produit répond aux critères suivants: